Giant cell arteritis: Difference between revisions
From IDWiki
Content deleted Content added
m Text replacement - "Clinical Presentation" to "Clinical Manifestations" |
m formatting |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Background== |
|||
Also known as temporal arteritis |
|||
*[[Large-vessel vasculitis]] that occurs in older age and is associated with polymyalgia rheumatica |
|||
== Definition == |
|||
*Also known as '''temporal arteritis''' |
|||
=== Epidemiology === |
|||
* Large-vessel vasculitis that occurs in older age and is associated with polymyalgia rheumatica |
|||
*Most common systemic vasculitis in North America |
|||
== |
=== Pathophysiology === |
||
*Granulomatous inflammation of the aortic arch and extracranial carotid artery |
|||
==Clinical Manifestations== |
|||
* Most common systemic vasculitis in North America |
|||
*After 50 years |
|||
== Pathophysiology == |
|||
*[[Headache]], usually unilateral with tenderness |
|||
*[[Polymyalgia rheumatica]] (PMR) |
|||
*Jaw claudication |
|||
*Visual loss |
|||
=== Prognosis === |
|||
* Granulomatous inflammation of the aortic arch and extracranial carotid artery |
|||
*Cycles of flares and remissions requiring adjustment in prednisone |
|||
*Very few can safely taper off of steroids altogether |
|||
==Investigations== |
|||
== ACR Classification Criteria == |
|||
*Temporal artery biopsy |
|||
* Requires 3 of 5 criteria |
|||
**Shows mononuclear cell infiltrate with granulomatous inflammation, and usually multinucleated giant cells |
|||
** Age ≥50 years |
|||
**Findings are still visible 6-12mo after starting therapy |
|||
** New localized headache |
|||
*Ultrasound of temporal arteries |
|||
** Temporal artery tenderness or decreased temporal artery pulse |
|||
**Looking for "halo sign" of hypoechoic ring around Doppler flow |
|||
** ESR ≥ 50 mm/h: 10-20% false negative, though |
|||
**Sn 55-100%, Sp 78-100% (more specific than sensitive) |
|||
** Artery biopsy consistent with GCA: Up to 40% false negative, related to skip lesions, small biopsies, or lack of temporal artery involvement |
|||
**Disappears quickly with treatment |
|||
* ''Not'' diagnostic criteria |
|||
*MRI scalp arteries |
|||
===McMaster Workup=== |
|||
== Clinical Manifestations == |
|||
*Initial investigation with ultrasound; if positive halo sign, can skip the rest |
|||
* After 50 years |
|||
*Low or moderate |
|||
* Headache, usually unilateral with tenderness |
|||
**Scalp artery MRI |
|||
* Polymyalgia rheumatica (PMR) |
|||
***Normal: treat based on MD diagnosis |
|||
* Jaw claudication |
|||
***Abnormal |
|||
* Visual loss |
|||
****Temporal artery biopsy |
|||
*****Negative: treat based on MD diagnosis (biopsy-negative GCA or other) |
|||
*****Positive: treat as GCA |
|||
*High |
|||
**Temporal artery biopsy |
|||
***Negative: treat based on MD diagnosis (biopsy-negative GCA or other) |
|||
***Positive: treat as GCA |
|||
== ACR Classification Criteria == |
|||
== Investigations == |
|||
*Requires 3 of 5 criteria |
|||
**Age ≥50 years |
|||
* Temporal artery biopsy |
|||
**New localized headache |
|||
** Shows mononuclear cell infiltrate with granulomatous inflammation, and usually multinucleated giant cells |
|||
**Temporal artery tenderness or decreased temporal artery pulse |
|||
** Findings are still visible 6-12mo after starting therapy |
|||
**[[ESR]] ≥ 50 mm/h: 10-20% false negative, though |
|||
* Ultrasound of temporal arteries |
|||
**Artery biopsy consistent with GCA: Up to 40% false negative, related to skip lesions, small biopsies, or lack of temporal artery involvement |
|||
** Looking for "halo sign" of hypoechoic ring around Doppler flow |
|||
*''Not'' diagnostic criteria |
|||
** Sn 55-100%, Sp 78-100% (more specific than sensitive) |
|||
** Disappears quickly with treatment |
|||
* MRI scalp arteries |
|||
=== McMaster Workup === |
|||
* Initial investigation with ultrasound; if positive halo sign, can skip the rest |
|||
* Low or moderate |
|||
** Scalp artery MRI |
|||
*** Normal: treat based on MD diagnosis |
|||
*** Abnormal |
|||
**** Temporal artery biopsy |
|||
***** Negative: treat based on MD diagnosis (biopsy-negative GCA or other) |
|||
***** Positive: treat as GCA |
|||
* High |
|||
** Temporal artery biopsy |
|||
*** Negative: treat based on MD diagnosis (biopsy-negative GCA or other) |
|||
*** Positive: treat as GCA |
|||
== Management == |
|||
* Prednisone 0.2-0.3mg/kg/day (and appropriate screening) |
|||
** Taper over 2 years, dropping by 5mg/d over a few weeks then slowing down |
|||
** Often aren't able to taper off altogether |
|||
* Low-dose ASA for cardiovascular and cerebrovascular protection |
|||
* Can consider adding steroid-sparing agent |
|||
** Tocilizumab (IL-6 receptor) |
|||
** Maybe methotrexate |
|||
** Not MMF or other DMARDs |
|||
* Follow ESR for response |
|||
* Annual chest x-rays for the first ten years, to monitor for thoracic aortic aneurysm |
|||
== |
==Management== |
||
*[[Prednisone]] 0.2-0.3mg/kg/day (and appropriate screening) |
|||
* Cycles of flares and remissions requiring adjustment in prednisone |
|||
**Taper over 2 years, dropping by 5mg/d over a few weeks then slowing down |
|||
* Very few can safely taper off of steroids altogether |
|||
**Often aren't able to taper off altogether |
|||
*Low-dose [[ASA]] for cardiovascular and cerebrovascular protection |
|||
*Can consider adding steroid-sparing agent |
|||
**[[Tocilizumab]] (IL-6 receptor) |
|||
**Maybe [[methotrexate]] |
|||
**Not [[MMF]] or other DMARDs |
|||
*Follow [[ESR]] for response |
|||
*Annual chest x-rays for the first ten years, to monitor for thoracic aortic aneurysm |
|||
[[Category:Rheumatology]] |
[[Category:Rheumatology]] |
||
Latest revision as of 18:32, 4 July 2025
Background
- Large-vessel vasculitis that occurs in older age and is associated with polymyalgia rheumatica
- Also known as temporal arteritis
Epidemiology
- Most common systemic vasculitis in North America
Pathophysiology
- Granulomatous inflammation of the aortic arch and extracranial carotid artery
Clinical Manifestations
- After 50 years
- Headache, usually unilateral with tenderness
- Polymyalgia rheumatica (PMR)
- Jaw claudication
- Visual loss
Prognosis
- Cycles of flares and remissions requiring adjustment in prednisone
- Very few can safely taper off of steroids altogether
Investigations
- Temporal artery biopsy
- Shows mononuclear cell infiltrate with granulomatous inflammation, and usually multinucleated giant cells
- Findings are still visible 6-12mo after starting therapy
- Ultrasound of temporal arteries
- Looking for "halo sign" of hypoechoic ring around Doppler flow
- Sn 55-100%, Sp 78-100% (more specific than sensitive)
- Disappears quickly with treatment
- MRI scalp arteries
McMaster Workup
- Initial investigation with ultrasound; if positive halo sign, can skip the rest
- Low or moderate
- Scalp artery MRI
- Normal: treat based on MD diagnosis
- Abnormal
- Temporal artery biopsy
- Negative: treat based on MD diagnosis (biopsy-negative GCA or other)
- Positive: treat as GCA
- Temporal artery biopsy
- Scalp artery MRI
- High
- Temporal artery biopsy
- Negative: treat based on MD diagnosis (biopsy-negative GCA or other)
- Positive: treat as GCA
- Temporal artery biopsy
ACR Classification Criteria
- Requires 3 of 5 criteria
- Age ≥50 years
- New localized headache
- Temporal artery tenderness or decreased temporal artery pulse
- ESR ≥ 50 mm/h: 10-20% false negative, though
- Artery biopsy consistent with GCA: Up to 40% false negative, related to skip lesions, small biopsies, or lack of temporal artery involvement
- Not diagnostic criteria
Management
- Prednisone 0.2-0.3mg/kg/day (and appropriate screening)
- Taper over 2 years, dropping by 5mg/d over a few weeks then slowing down
- Often aren't able to taper off altogether
- Low-dose ASA for cardiovascular and cerebrovascular protection
- Can consider adding steroid-sparing agent
- Tocilizumab (IL-6 receptor)
- Maybe methotrexate
- Not MMF or other DMARDs
- Follow ESR for response
- Annual chest x-rays for the first ten years, to monitor for thoracic aortic aneurysm